Hepatitis C Virus and Insulin Resistance
Author Information
Author(s): Francesco Negro
Primary Institution: University of Geneva Medical Center
Hypothesis
Does hepatitis C virus infection directly interfere with insulin signaling and contribute to insulin resistance?
Conclusion
Hepatitis C virus infection is associated with insulin resistance, particularly in patients with genotype 3a, which may complicate treatment responses.
Supporting Evidence
- Insulin resistance is more prevalent in chronic hepatitis C patients, especially those over 40.
- HCV may directly interfere with insulin signaling pathways.
- Successful antiviral therapy reduces insulin resistance in chronic hepatitis C patients.
Takeaway
Hepatitis C can make it harder for your body to use insulin, which is important for controlling blood sugar. This can lead to diabetes.
Methodology
The article reviews existing studies on the relationship between hepatitis C virus and insulin resistance, focusing on genotype-specific effects.
Potential Biases
Potential biases may arise from the limited sample sizes and the focus on specific patient demographics.
Limitations
The data available are limited and primarily focus on genotype 3a, with little information on other genotypes.
Participant Demographics
Patients included were primarily those with chronic hepatitis C, with a focus on genotype 3a and varying degrees of liver fibrosis.
Statistical Information
P-Value
0.007
Statistical Significance
p=0.007
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website